Skip to main content
Premium Trial:

Request an Annual Quote

Precision BioSciences, Agrivida Ink Feedstock Trait Genetic Modification Pact

NEW YORK (GenomeWeb News) – Precision BioSciences and Agrivida have struck an agreement to use Precision Bio's genetic modification technology to develop traits in corn that can improve animal nutrition for the dairy and beef industries.

The partners will use Precision Bio's Directed Nuclease Editor (DNE) technology, which enables production of genome-editing enyzmes that can insert, remove, modify, and regulate genes in mammalian and plant cells, Research Triangle Park, NC-based Precision said today.

Located in Medford, Mass., Agrivida develops products that incorporate regulated proteins that are engineered for specific applications, including biomass feedstock for animal nutrition, bio-based fuels and chemicals, and industrial enzymes.

"The opportunity for improving the nutritional characteristics of crops for the dairy and beef market segments is significant," Agrivida CEO Dan Meagher said in a statement. He added that Precision Bio's DNE technology has delivered a compositional modification that will help boost productivity of ruminant animals that eat plants expressing a trait they have already developed.

Financial and other terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.